|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
5
|
|
pubmed:dateCreated |
2002-3-28
|
|
pubmed:abstractText |
Prognostic factors for solitary plasmacytoma of bone (SPB), whether measured before or after radiotherapy (RT), have not been established. The authors analyzed multiple factors for myeloma-free survival (MFS) and cause-specific survival (CSS) in SPB patients treated with RT alone.
|
|
pubmed:grant |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
AIM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Mar
|
|
pubmed:issn |
0008-543X
|
|
pubmed:author |
|
|
pubmed:copyrightInfo |
Copyright 2002 American Cancer Society.
|
|
pubmed:issnType |
Print
|
|
pubmed:day |
1
|
|
pubmed:volume |
94
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
1532-7
|
|
pubmed:dateRevised |
2007-11-14
|
|
pubmed:meshHeading |
pubmed-meshheading:11920511-Adult,
pubmed-meshheading:11920511-Aged,
pubmed-meshheading:11920511-Bone Neoplasms,
pubmed-meshheading:11920511-Disease-Free Survival,
pubmed-meshheading:11920511-Female,
pubmed-meshheading:11920511-Follow-Up Studies,
pubmed-meshheading:11920511-Humans,
pubmed-meshheading:11920511-Magnetic Resonance Imaging,
pubmed-meshheading:11920511-Male,
pubmed-meshheading:11920511-Middle Aged,
pubmed-meshheading:11920511-Multiple Myeloma,
pubmed-meshheading:11920511-Myeloma Proteins,
pubmed-meshheading:11920511-Plasmacytoma,
pubmed-meshheading:11920511-Prognosis,
pubmed-meshheading:11920511-Time Factors,
pubmed-meshheading:11920511-Tomography, X-Ray Computed
|
|
pubmed:year |
2002
|
|
pubmed:articleTitle |
Persistence of myeloma protein for more than one year after radiotherapy is an adverse prognostic factor in solitary plasmacytoma of bone.
|
|
pubmed:affiliation |
Department of Radiation Oncology, M.D. Anderson Cancer Center, Houston, Texas, USA. rwilder@mdanderson.org
|
|
pubmed:publicationType |
Journal Article,
Research Support, U.S. Gov't, P.H.S.
|
